Notable
ASIST · BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma
Primary completion pushed from Apr 2026 to Nov 2026
Bexion Pharmaceuticals, Inc.Phase 1/2 NCT05322590 Registry history of NCT05322590 on ClinicalTrials.gov (opens the registry)